Services are often outsourced to third party vendors for certain clinical trial activities, particularly where a clinical trial activity must be standardised. Such vendor services can include a centralised review… read more →
AusTrade’s latest Clinical Trials Capability Report has some interesting facts n figures Between 2012 and 2015, phase I activity has grown by 17.2% in Australia, compared to 1.8% globally Between… read more →
What is Risk Based Monitoring? Risk based monitoring is a new monitoring model that has been accepted by the European Medicines Agency and the Food and Drug Administration. It is… read more →
We are excited to announce the opening of our new office in Melbourne Melbourne is globally recognised as a leading Biotech innovation hub and Mobius has several large projects running… read more →
Mobius Medical is pleased to announce that BSI has granted ISO:9001 certification for our Quality Management System. We’re proud of our QMS having worked on it over several years to… read more →
Attending AdvaMed in Minneapolis this year are the two founding members and Principals of the SME’s favoured boutique CRO in Australia and New Zealand Stefan Czyniewski and Suzanne Williams will be… read more →
We’re looking for amazing people skills, confidence and ability to get along with the trickiest of site staff, and a happy, can-do attitude is essential. Technical skills, GCP practical… read more →
Principal investigators are often asked by their patients if they can still access the investigational product (IP) after they have completed the clinical trial. In some medical device trials, using… read more →
Australia and New Zealand have each registered more clinical trials (per capita) than Germany, UK and the USA according to the World Health Organisation International Clinical Trials Registry Platform! The… read more →
Recent Comments